Predictive Value of Adiposity Level, Metabolic Syndrome, and Insulin Resistance for the Risk of Nonalcoholic Fatty Liver Disease Diagnosis in Obese Children

Table 5

Prevalence of metabolic factors in NAFLD and non-NAFLD group.

MS components	Total (%)	NAFLD patients ()	Patients without NAFLD ()
WC > 90 pc	108 (100%)	49 (100%)	59 (100%)	NS
TG > 150 mg/dl or hypolipemic treatment	49 (45.37%)	30 (61.22%)	19 (32.20%)	0.002
HDL < 40 mg/dl (girls > 16 years; HDL < 50 mg/dl)	39 (36.11%)	20 (40.82%)	19 (32.20%)	NS
Hypertension	21 (19.44%)	11 (22.45%)	10 (16.95%)	NS
IFG or diabetes 2	13 (12.04%)	6 (12.24%)	7 (11.86%)	NS
MS	34 (31.48)	20 (40.82)	14 (23.73)	0.04